Icon of the Instituts for Quality and Efficiency in Health Care

Report

Cholinesterase inhibitors in Alzheimer's disease

Status
Status: Commission completed
Project no.
A05-19A
Last updated

Report documents

  1. Executive summary of the final report

    Cholinesterase inhibitors in Alzheimer's disease

    published on
    Document type
    PDF-Dokument, 53 kB, EN, PDF
    Download file : Executive summary of the final report (PDF-Dokument, 53 kB, EN, PDF)

  2. Final report

    Cholinesterase inhibitors in Alzheimer's disease

    published on
    Document type
    PDF-Dokument, 1 MB, EN, PDF
    Download file : Final report (PDF-Dokument, 1 MB, EN, PDF)

  3. Preliminary report

    Cholinesterase inhibitors in Alzheimer's disease

    published on
    Document type
    PDF-Dokument, 2 MB, DE, PDF
    Download file : Preliminary report (PDF-Dokument, 2 MB, DE, PDF)

  4. Amendment 1 to the report plan version 1.0

    Cholinesterase inhibitors in Alzheimer's disease

    published on
    Document type
    PDF-Dokument, 37 kB, DE, PDF
    Download file : Amendment 1 to the report plan version 1.0 (PDF-Dokument, 37 kB, DE, PDF)

  5. Report plan version 1.0

    Cholinesterase inhibitors in Alzheimer's disease

    published on
    Document type
    PDF-Dokument, 83 kB, DE, PDF
    Download file : Report plan version 1.0 (PDF-Dokument, 83 kB, DE, PDF)

Press releases

Alzheimer’s disease: only a few therapies provide proof of benefit to patients

Cholinesterase inhibitors and ginkgo may alleviate some symptoms – Non-drug approaches are insufficiently investigated – Marked increase in supporting research
Press release

Cholinesterase inhibitors can slightly delay the deterioration of cognitive function

IQWiG publishes final report on a drug class for treatment of Alzheimer's disease
Press release

Additional information

IQWiG health information

How effective are cholinesterase inhibitors?

Project details

Project no.
A05-19A
Commission
Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Head and nerves

Connected Projects

  1. Report

    Cholinesterase inhibitors in Alzheimer's disease - supplementary commission: rivastigmine patches and galantamine

    Project no.
    A09-05
    Last updated

    Status: Commission completed

  2. Rapid report

    Update search on Report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) - Rapid report

    Project no.
    A09-03
    Last updated

    Status: Commission completed

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page